MBII Marrone Bio Innovations Inc

Marrone Bio Innovations’ Regalia® Maxx Biofungicide Approved in Chile

Marrone Bio Innovations, Inc.(MBI), (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its flagship biofungicide, REGALIA MAXX, is now registered in Chile.

Chile produces a wide range of fruits, nuts and vegetables for export, and therefore needs solutions to manage chemical residues at time of harvest. Biopesticides like REGALIA MAXX can be applied right up to harvest, providing growers and exporters end of season protection, flexibility, and peace of mind. Chilean growers have been early adopters of biopesticides, recognizing the need to minimize residues, while maintaining or enhancing yields and quality.

REGALIA MAXX, based on an extract of Giant Knotweed (Reynoutria sachalinensis), prevents and fights crop diseases by triggering treated plants to produce disease-fighting biochemicals (Induced Systemic Resistance), while simultaneously enhancing plant health, crop yield and crop quality. REGALIA MAXX is safe to workers, crops, beneficials and pollinators and can be sprayed right up to harvest to manage residues for export. REGALIA also has the minimum restricted-entry interval for workers to enter the field after spraying, increasing operational flexibility.

The REGALIA MAXX label was developed by FMC in Chile for three important exported crops 1) Table and wine grapes: powdery mildew (Erysiphe necator) and a complex of plant pathogens that cause and contribute to fruit rot (Botrytis cinérea, Cladosporium herbarium, Penicillium expansum, Rhizopus stolonifer,), 2) Blueberries: blossom blight (Botrytis cinérea), and 3) Walnuts: walnut blight (Xanthomonas arborícola pv. juglandis).

There are over 183,000 hectares (close to 475,000 acres) of grapes in Chile, approximately two-thirds are wine grapes. Chile is the 8th largest wine producer and the 5th largest wine exporter in the world. 70% of Chile’s wine is exported. Chile is the world’s number one exporter of table grapes, with 27% of the global market. In 2015, table grape exports were 740,000,000 metric tons worth approximately $1 billion1.

Blueberry production in Chile has experienced high growth from 1,360 hectares in 2005 to more than 14,500 hectares (36,000 acres) in 2014, with exports topping $500 million in value. Chile’s blueberry acreage continued to expand in 2015, with 15,900 hectares (almost 40,000 acres) planted. Leading blueberry production region Maule will export a projected 80 million pounds in 2015-16, a 35% increase over 2014-15, according to the Chilean Blueberry Committee. Chile exports between 60% and 70% of its production primarily to the United States and Europe.1

Walnuts is an emerging crop for Chile with nearly 30,000 hectares (almost 75,000 acres) of walnuts. Chile expects to double production in the next five years.2

These markets represent an excellent growth opportunity for Regalia Maxx, according to FMC. Under an agreement with MBI, FMC now distributes REGALIA MAXX in Chile, Brazil, Peru, Mexico and some other Latin American countries.

REGALIA MAXX is an excellent resistance management tool,” said Juan Pable Luco, FMC Agricultural Solutions Country Manager for Chile and Peru. “By offering a different mode of action, REGALIA MAXX expands growers’ options and will help producting better quality crops. We are pleased to add an effective Biofungicide for integrated disease and residue management programs in Chile.”

REGALIA MAXX is now registered in 10 countries in the LATAM region.

1   Source: Office of Agricultural Studies and Policies (PASO)
2 Sources: Eurofresh Distribution, CropLife Foundation, USDA-FAS.
3 Source: Chilean Walnut Commission

About FMC Corporation

For more than a century, FMC Corporation has served the global agricultural, industrial and consumer markets with innovative solutions, applications and quality products. FMC acquired Cheminova in April 2015. Revenue totaled approximately $3.3 billion in 2015. FMC employs approximately 6,000 people throughout the world and operates its businesses in three segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Lithium. For more information, visit www.FMC.com.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have four products for agriculture on the market (Regalia®, Grandevo®, Venerate® and Majestene®), and also distribute Bio-tam 2.0® for Isagro USA in the western U.S. We market Zequanox® for invasive mussels for water markets. We also have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations, we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Marrone Bio Innovations Forward Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding the potential of and market for MBI’s REGALIA MAXX product and its use and value to growers. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company's control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including risks associated with marketing MBI’s Regalia with MBI’s principal customers, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, adverse decisions by regulatory agencies and other relevant third parties and the impact of weather conditions and other factors affecting use of crop protection products. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

EN
05/12/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Marrone Bio Innovations Inc

 PRESS RELEASE

Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement wi...

Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp. RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement), dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp. (BIOX), BCS Merger Sub, Inc., and MBI, pursuant to which MBI will be acquired by BIOX. At the special meeting, MBI’s stockholde...

 PRESS RELEASE

Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Res...

Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: Higher sales of row crop products in the first quarter were somewhat offset by lower sales into specialty crop markets, which were affected by adverse weather conditions. Based on the strength of current orders, revenues in the first half are expected to increase in the ...

 PRESS RELEASE

Marrone Bio Innovations to Report First Quarter 2022 Results on Wednes...

Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2022, after market close on Wednesday, May 11, 2022. Management will host an investor conference call at 4:30 p.m. ET to discuss Marrone Bio Innovations’ first quarter financial re...

 PRESS RELEASE

Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 202...

Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2021. Key results include: Full year revenues rose 15.5%, with a 40.2% increase in the fourth quarter.Gross profit grew 19.1% and 31.5% for the full year and fourth quarter, respectively, with margins exceeding 59% in both periods.For the full year, net loss was ...

 PRESS RELEASE

Marrone Bio Expands Biological Seed Treatment Collaboration for Row Cr...

Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), has signed an agreement with Corteva Agriscience (NYSE: CTVA) that expands the opportunity for MBI technologies to be used on seeds sold by Corteva for row crops globally. Marrone Bio currently provides seed treatment solutions to Corteva for use throughout Europe. MBI introduced biological seed treatments as a sustainable alternative to control yield-robbing pests in the United States i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch